Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 21, 2016; 22(7): 2336-2341
Published online Feb 21, 2016. doi: 10.3748/wjg.v22.i7.2336
Published online Feb 21, 2016. doi: 10.3748/wjg.v22.i7.2336
Table 2 Follow up and recurrence after endoscopic resection
| Use of adjuvant therapy | ||||
| Case | After ESD | Follow up interval | Recurrence pattern | Time to recurrence |
| 1 | - | 3 mo | Distant metastasis (lung, PALN) | 8 mo |
| 2 | - | Every year | Local + regional lymphnode | 10 mo |
| 3 | - | No follow | Distant metastasis (lung, liver) | 7 yr |
| 4 | - | 8 mo | Local | 4 yr |
| 5 | - | No follow | Local + regional lymphnode | 18 mo |
| 6 | XELOX 6 mo | No follow | Local | 2 yr |
| 7 | - | Every year | Local + regional lymphnode | 4 yr |
| 8 | - | No follow | Peritoneal dissemination | 4 yr |
- Citation: Takatsu Y, Fukunaga Y, Hamasaki S, Ogura A, Nagata J, Nagasaki T, Akiyoshi T, Konishi T, Fujimoto Y, Nagayama S, Ueno M. Recurrent colorectal cancer after endoscopic resection when additional surgery was recommended. World J Gastroenterol 2016; 22(7): 2336-2341
- URL: https://www.wjgnet.com/1007-9327/full/v22/i7/2336.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i7.2336